Mirafuentes, Baby Girl .
HRN: 24-99-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/15/2024
05/22/2024
IV
56mg
Q24hours
T/c Sepsis Sec To PCAP-severe
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaBloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes